Strong Buy
Average AnalystStrong Buy
Top AnalystSlightly Bearish
Stock Target AdvisorN/A
Average UserUSD 2.23
-0.05 (-2.19%)
USD 0.78B
1.61M
USD 7.50(+236.32%)
Based on the Nuvation Bio Inc stock forecast from 4 analysts, the average analyst target price for Nuvation Bio Inc is USD 7.50 over the next 12 months. Nuvation Bio Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Nuvation Bio Inc is Slightly Bearish, which is based on 2 positive signals and 4 negative signals. At the last closing, Nuvation Bio Inc’s stock price was USD 2.23. Nuvation Bio Inc’s stock price has changed by -7.47% over the past week, -19.78% over the past month and +26.70% over the last year.
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The company had positive total free cash flow in the most recent four quarters.
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
The company had negative total cash flow in the most recent four quarters.
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.